From Risk to Resilience: Healthcare Providers and the Psychedelic Therapy Revolution
Currently, MDMA-assisted therapy for PTSD and psilocybin for depression disorders await approval from the FDA. Meanwhile, practitioners are creating spaces to give their patients this revolutionary experience.